共 181 条
[1]
Abbott AM(2015)Outcomes of therasphere radioembolization for colorectal metastases Clin Colorectal Cancer 14 146-153
[2]
Kim R(2015)Radioembolization using yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience Transplant Proc 47 408-411
[3]
Hoffe SE(2011)Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for hepatic neuroendocrine metastases: initial experience at a single center. Vojnosanitetski pregled Mil Med Pharm Rev 68 341-348
[4]
Abdelfattah MR(2016)Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases Eur J Nucl Med Mol Imaging 43 1425-1431
[5]
Al-Sebayel M(2016)Selektive interne Radioembolisation beim nichtresektablen hepatozellulären Karzinom Chirurg 87 956-963
[6]
Broering D(2012)Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients J Vasc Interv Radiol 23 96-105
[7]
Arslan N(2017)Radioembolization-induced liver disease: a systematic review Eur J Gastroenterol Hepatol 29 144-152
[8]
Emi M(2014)Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization J Vasc Interv Radiol 25 256-265
[9]
Alagoz E(2010)Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases Br J Surg 97 537-543
[10]
Barbier CE(2000)Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 190 432-445